Transfer of Value Reporting

Our Approach

BioMarin is a world leader in developing and commercialising first- or best-in-class therapies for rare genetic diseases. Healthcare professionals are vital partners for BioMarin, providing us with essential scientific and medical expertise and valuable insights into patient care. These relationships are pivotal in ensuring the continued development of treatments for rare diseases and to help meet patient and public health needs.

We believe in fair compensation and legitimate interactions with healthcare professionals and related organisations. We adhere at all times to our corporate standards and applicable laws and industry codes relating to the nature and extent of our interactions.

Disclosure of Payments and Transfers

As part of our regional transparency reporting obligations, BioMarin discloses certain payments made to healthcare professionals and healthcare organisations. These disclosures have either been reported in accordance with the local authorities’ reporting system or on this website. The payments and transfers of value disclosed here were made for activities such as providing professional advice about how medicines are used in practice, sharing professional expertise at medical education meetings, taking part in advisory boards, research and educational grants.